UCSF

Tagged: QBI Coronavirus Research Group

QBI probes three lethal coronaviruses to find possible drug targets

“This is looking across coronaviruses and finding the commonalities so we’re in a better position to attack SARS3 when it comes,” said Nevan Krogan, the director of QBI.

Danica Fujimori Receives Bowes Biomedical Investigator Award

Danica Galonić Fujimori, PhD, will receive $1.25 million in funding over the next five years from the endowment of the late William K. Bowes, Jr., a venture capitalist and longtime UCSF supporter.

Nanobody-based antiviral developed at UCSF effectively blocks SARS-CoV-2 in the lab

School scientists developed an antiviral that fights SARS-CoV-2 that can be given as a nasal spray.

How targeting a key SARS-CoV-2 enzyme could lead to an antiviral drug

The chemical fragments could bind to and disable an enzyme that helps the virus replicate.

SARS-CoV-2 may spur growth of molecular “railways” out of infected cells, School scientists show

UCSF-led collaboration uncovers new avenues for COVID-19 drug discovery

QBI Coronavirus Research Group identifies drugs that block SARS-CoV-2 in the laboratory

The QBI Coronavirus Research Group found six drugs that effectively beat back SARS-COV-2 in the laboratory.

QBI Coronavirus Research Group races toward a cure

The UCSF Quantitative Biosciences Institute has made headway identifying dozens of potential therapies for the COVID-19 outbreak.

Hunting for a cure for COVID-19: an insider’s story

The chief operating officer of the Quantitative Biosciences Institute (QBI) shares a view of the team's work on COVID-19.